Ceyla, I. Et Al. 2012. Fractalkine (CX3CL1) levels in patients with Behçet's disease and Neuro-Behçet's disease. Journal of the Neurological Sciences , vol.315, no.1-2 , 120-122.

Ceyla, I., Tuba, T. K., Esra, A., Banu, O., Isil, F., AKCAYOL, M. A., ... Turgut, I.(2012). Fractalkine (CX3CL1) levels in patients with Behçet's disease and Neuro-Behçet's disease. Journal of the Neurological Sciences , vol.315, no.1-2, 120-122.

Ceyla, CEYLA Et Al. "Fractalkine (CX3CL1) levels in patients with Behçet's disease and Neuro-Behçet's disease," Journal of the Neurological Sciences , vol.315, no.1-2, 120-122, 2012

Ceyla, CEYLA Et Al. "Fractalkine (CX3CL1) levels in patients with Behçet's disease and Neuro-Behçet's disease." Journal of the Neurological Sciences , vol.315, no.1-2, pp.120-122, 2012

Ceyla, I. Et Al. (2012) . "Fractalkine (CX3CL1) levels in patients with Behçet's disease and Neuro-Behçet's disease." Journal of the Neurological Sciences , vol.315, no.1-2, pp.120-122.

@article{article, author={CEYLA İRKEÇ Et Al. }, title={Fractalkine (CX3CL1) levels in patients with Behçet's disease and Neuro-Behçet's disease}, journal={Journal of the Neurological Sciences}, year=2012, pages={120-122} }